Enhanced alveolar clearance with chest percussion therapy and positional changes during whole-lung lavage for alveolar proteinosis

Chest

Volumn 125, Issue 6, 2004, Pages 2351-2356

  Perez IV, Andrew ^a   Rogers, Robert M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alveolar proteinosis; Lung diseases; Pulmonary BAL; Respiratory tract diseases

Indexed keywords

ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRY WEIGHT; EFFLUENT; HUMAN; LUNG ALVEOLUS PROTEINOSIS; LUNG CLEARANCE; LUNG DIFFUSION; LUNG LAVAGE; PATIENT POSITIONING; PERCUSSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 2942731316     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2351     Document Type: Article

References (23)

1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258:1123-1142
2. Shall PL, Hansell D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55:67-77
3. Kavuru MS, Popovich M. Therapeutic whole lung lavage: a stop-gap therapy for alveolar proteinosis. Chest 2002; 122:1123-1124
4. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166:215-235
5. Seidman JM, Sasahara AA. Bronchopulmonary lavage. N Engl J Med 1972; 286:1262-1263
6. Rogers RM, Levin DC, Gray BA, et al. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978; 118:255-264
7. Rogers RM, Szidon JP, Shelburne J, et al. Hemodynamic response of the pulmonary circulation to bronchopulmonary lavage in man. N Engl J Med 1972; 286:1230-1233
8. Martin RJ, Rogers RM, Myers NM. Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis 1978; 117:1059-1062
9. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984; 85:550-558
10. Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest 1993; 103:1409-1412
11. Rogers RM, Levin DC, Gray BA, et al. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis 1978; 118:255-264
12. Strong P, Kishore U, Morgan C, et al. A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods 1998; 220:139-149
13. Cheng SL, Chang HT, Lau HP, et al. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest 2002; 122:1480-1485
14. Bingisser R, Kaplan V, Zollinger A, et al. Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest 1998; 113:1718-1719
15. Ishikawa NKK, Oguri T, Kamitsuna M, et al. Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis. Intern Med 2002; 41:381-385
16. Bonfield TL, Russell D, Burgess S, et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002; 27:481-486
17. Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 2002; 105:342-350
18. Tanaka N, Watanabe J, Kitamura T, et al. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 1999; 442:246-250
19. Carraway MS, Ghio AJ, Carter JD, et al. Detection of granulocyte- macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 161:1294-1299
20. Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162:658-662
21. Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163:524-531
22. Kavuru MS, Sullivan EJ, Piccin R, et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 161:1143-1148
23. Barraclough RM, Gillies AJ. Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 2001; 56:664-665